Christopher J Black (Christopher Black)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 70

Top Topics

Systematic Review

Irritable Bowel Syndrome

Helicobacter Pylori

Top Venues

Alimentary pharmacology & therapeutics

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

Neurogastroenterology and motility

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut (2024)
Christopher J Black, David J Gracie
Editorial: A Mediterranean diet for IBS-Is healthy and inclusive eating the way forward? Alimentary pharmacology & therapeutics 59 (4) (2024)
Mais Khasawneh, Fahad Ali Shaikh, Cho Ee Ng, Christopher J Black, Vivek C Goodoory, Alexander C Ford
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology and motility (2024)
Christopher J Black
Editorial: Disorders of gut-brain interaction-Don't forget the older person. Alimentary pharmacology & therapeutics (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Christopher J Black, Peter A Paine, Alexander Charles Ford
Letter to the editor: Helicobacter pylori eradication, the proof is not in the symptoms-authors' reply. Gut (2024)
Mais Khasawneh, Fahad Ali Shaikh, Cho Ee Ng, Christopher J Black, Vivek C Goodoory, Alexander C Ford
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology and motility 36 (4) (2024)
Christopher J Black, David J Gracie
Editorial: A Mediterranean diet for IBS-Is healthy and inclusive eating the way forward? Alimentary pharmacology & therapeutics 59 (4) (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Mais Khasawneh, Fahad Ali Shaikh, Cho Ee Ng, Christopher J Black, Vivek C Goodoory, Alexander C Ford
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology and motility 36 (4) (2024)
Christopher J Black
Editorial: Disorders of gut-brain interaction-Don't forget the older person. Alimentary pharmacology & therapeutics 60 (4) (2024)
Maura Corsetti, Andrea S Shin, Christopher J Black, Daniel Keszthelyi, Fedias L Christofi, Frank Zerbib, Kirsteen Browning, Michael Jones
Neurogastroenterology and Motility gets younger! Neurogastroenterology and motility (2023)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Christy Riggott, Keeley M Fairbrass, Christopher J Black, David J Gracie, Alexander Charles Ford
Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary pharmacology & therapeutics (2023)
Vivek Chand Goodoory, Cho E Ng, Christopher J Black, Alexander Charles Ford
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics (2023)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Hussain Jaafari, Lesley A Houghton, Robert M West, Anurag Agrawal, Imran Aziz, Christopher J Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A Paine, Alexander Charles Ford, Peter J Whorwell, Shrikant I Bangdiwala, Olafur S Palsson, Ami D Sperber, Dipesh Harshvadan Vasant
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Vivek C Goodoory, Cho E Ng, Christopher J Black, Alexander Charles Ford
Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome-authors' reply. Alimentary pharmacology & therapeutics 58 (1) (2023)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Kee-Huat Chuah, Christopher J Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong Yeh Lee, Sanjiv Mahadeva, Alexander Charles Ford
Editorial: Recognising the regional variations in profile of irritable bowel syndrome-better late than never! Authors' reply. Alimentary pharmacology & therapeutics 58 (4) (2023)
Heidi M Staudacher, Christopher J Black, Scott B Teasdale, Antonina Mikocka-Walus, Laurie Keefer
Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nature reviews. Gastroenterology & hepatology (2023)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Kee-Huat Chuah, Christopher J Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong Yeh Lee, Sanjiv Mahadeva, Alexander Charles Ford
A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care. Alimentary pharmacology & therapeutics (2023)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Maura Corsetti, Frank Zerbib, Christopher J Black, Andrea S Shin, Kirsteen Browning, Fedias Chistofi, Daniel Keszthelyi
News from the Editors. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' reply. Alimentary pharmacology & therapeutics 57 (6) (2023)
Pierfrancesco Visaggi, Brigida Barberio, Giulio Del Corso, Nicola de Bortoli, Christopher J Black, Alexander Charles Ford, Edoardo Vincenzo Savarino
Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut (2023)
Vivek C Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Alimentary pharmacology & therapeutics 56 (1) (2022)
Shahida Din, Christian P Selinger, Christopher J Black, Alexander Charles Ford
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (6) (2022)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho E Ng, Christopher J Black, Alexander Charles Ford
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics 57 (3) (2022)
Christopher J Black, Lesley A Houghton, Alexander Charles Ford
Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 34 (11) (2022)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho E Ng, Christopher J Black, Alexander Charles Ford
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics 57 (3) (2022)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Impact of Rome IV irritable bowel syndrome on work and activities of daily living. Alimentary pharmacology & therapeutics 56 (5) (2022)
Shahida Din, Christian P Selinger, Christopher J Black, Alexander Charles Ford
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (6) (2022)
Shahida Din, Christian P Selinger, Christopher J Black, Alexander Charles Ford
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary pharmacology & therapeutics (2022)
Maria Rosa Ingrosso, Gianluca G Ianiro, Judy W Nee, Anthony J Lembo, Paul Moayyedi, Christopher J Black, Alexander Charles Ford
Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply. Alimentary pharmacology & therapeutics 56 (7) (2022)
Christopher J Black, Alexander Charles Ford
Letter in response to Black et al. (2020): Authors' Reply. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 34 (6) (2022)
Vivek C Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: estimating the costs of care in irritable bowel syndrome-a necessary step to enhance value-based care for a high-prevalence, low-cost condition. Authors' reply. Alimentary pharmacology & therapeutics 55 (12) (2022)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Brigida Barberio, Pierfrancesco Visaggi, Edoardo Vincenzo Savarino, Nicola de Bortoli, Christopher J Black, Alexander Charles Ford
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply. Alimentary pharmacology & therapeutics 56 (5) (2022)
Christopher J Black, Peter A Paine, Anurag Agrawal, Imran Aziz, Maria P Eugenicos, Lesley A Houghton, Pali Hungin, Ross Overshott, Dipesh H Vasant, Sheryl Rudd, Richard C Winning, Maura Corsetti, Alexander Charles Ford
British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut 71 (9) (2022)
Maria Rosa Ingrosso, Gianluca G Ianiro, Judy W Nee, Anthony J Lembo, Paul Moayyedi, Christopher J Black, Alexander Charles Ford
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary pharmacology & therapeutics 56 (6) (2022)
Christopher J Black
Review article: Diagnosis and investigation of irritable bowel syndrome. Alimentary pharmacology & therapeutics (2022)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho E Ng, Christopher J Black, Alexander Charles Ford
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics (2022)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho E Ng, Christopher J Black, Alexander Charles Ford
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics 57 (3) (2022)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics 55 (10) (2022)
Vivek Chand Goodoory, Elspeth A Guthrie, Cho E Ng, Christopher J Black, Alexander Charles Ford
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary pharmacology & therapeutics 57 (3) (2022)
Shahida Din, Christian P Selinger, Christopher J Black, Alexander Charles Ford
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (6) (2022)
Vivek Chand Goodoory, Cho Ee Ng, Christopher J Black, Alexander Charles Ford
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply. Alimentary pharmacology & therapeutics 55 (9) (2022)
Brigida Barberio, David J Gracie, Christopher J Black, Alexander Charles Ford
Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis. Gut (2022)
Alfred D Nelson, Christopher J Black, Lesley A Houghton, Nahyr Sofía Lugo-Fagundo, Brian E Lacy, Alexander Charles Ford
Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply. Alimentary pharmacology & therapeutics 54 (2) (2021)
Vivek Chand Goodoory, Orla F Craig, David J Gracie, Christopher J Black, Alexander Charles Ford
Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
Christopher J Black, Heidi M Staudacher, Alexander Charles Ford
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut (2021)
Nicholas E Burr, David J Gracie, Christopher J Black, Alexander Charles Ford
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. Gut (2021)
Alfred D Nelson, Christopher J Black, Lesley A Houghton, Nahyr Sofía Lugo-Fagundo, Brian E Lacy, Alexander Charles Ford
Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Alimentary pharmacology & therapeutics 54 (2) (2021)
Dipesh Harshvadan Vasant, Peter A Paine, Christopher J Black, Lesley A Houghton, Hazel A Everitt, Maura Corsetti, Anurag Agrawal, Imran Aziz, Adam D Farmer, Maria P Eugenicos, Rona Moss-Morris, Yan Yiannakou, Alexander Charles Ford
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 70 (7) (2021)
Christopher J Black, Yan Yiannakou, Elspeth Guthrie, Robert West, Lesley A Houghton, Alexander Charles Ford
Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value. Alimentary pharmacology & therapeutics 53 (10) (2021)
Vivek Chand Goodoory, Lesley A Houghton, Christopher J Black, Alexander Charles Ford
Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
Christopher J Black, Alexander Charles Ford
Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management-authors' reply. Alimentary pharmacology & therapeutics 53 (10) (2021)
Brigida Barberio, Edoardo Vincenzo Savarino, Christopher J Black, Alexander Charles Ford
Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
Christopher J Black, Alexander Charles Ford
Faecal incontinence is not rare in irritable bowel syndrome. Frontline gastroenterology 11 (6) (2020)
Christopher J Black, Alexander C Ford
Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature reviews. Gastroenterology & hepatology 17 (8) (2020)
Christopher J Black, Yan Yiannakou, Lesley A Houghton, Farag Shuweihdi, Robert West, Elspeth Guthrie, Alexander Charles Ford
Anxiety-related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 32 (8) (2020)
Christopher J Black, Alexander Charles Ford
Best management of irritable bowel syndrome. Frontline gastroenterology 12 (4) (2020)
Christopher J Black, Orla Craig, David J Gracie, Alexander Charles Ford
Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut 70 (6) (2020)
Shujing Jane Lim, David J Gracie, John S Kane, Saqib Mumtaz, Andrew F Scarsbrook, Fahmid U Chowdhury, Alexander Charles Ford, Christopher J Black
Prevalence of, and predictors of, bile acid diarrhea in outpatients with chronic diarrhea: A follow-up study. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 31 (9) (2019)